button bars forest bayes pooled summary circles
 
deaths (OS)progression or deaths (PFS)RFS/DFS

mHCC - 2nd line (L2) metastatic/advanced hepatocellular cancer (mHCC) mHCC - 2nd line (L2)

versus placebo
pembrolizumab alone vs. placebo 1 certainty unassessable-20% certainty unassessable-26%-
pembrolizumab based treatment vs. placebo 1 certainty unassessablestatistically conclusive-20% certainty unassessablestatistically conclusive-25%-

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons